1800 202 8726
Chemotherapy regimen

FOLFIRINOX and Modified FOLFIRINOX: — The Four Drugs Explained

If your oncologist has written FOLFIRINOX on your chart, you are looking at a regimen that combines four drugs — and side effects that can come from all four at once. This page explains what each drug is, why the side effects are significant, and what the modified version means.

  • Four drugs combined — The name FOLFIRINOX encodes each component: folinic acid, fluorouracil, irinotecan, and oxaliplatin.
  • Side effects from multiple directions — Running three cytotoxic agents together means fatigue, nerve effects, blood count changes, and gut symptoms can all occur.
  • Modified version exists — mFOLFIRINOX uses the same four drugs in adjusted amounts — chosen when the full regimen is likely to be too hard on the body.
  • Requires a port or central line — One drug is given as a slow continuous infusion. A port or central line is placed before treatment begins.

Medically reviewed by Dr. Owais Mohammed, Medical Oncologist · Last reviewed September 2026

Prescription-only medicine. FOLFIRINOX is a prescription-only chemotherapy regimen administered under the supervision of a specialist oncologist in a clinical setting. It cannot be started, modified, or stopped on the basis of anything read online or without direct assessment and ongoing monitoring by a treating team. Nothing on this page is a recommendation to use this medicine. It is not suitable for most patients — see "Who this is not for" below.

Ask about your own treatment

A senior medical oncologist reviews what you send and replies in writing.

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.

FOLFIRINOX combines four drugs — folinic acid, fluorouracil (5-FU), irinotecan, and oxaliplatin — into one regimen. The side effects come from all four directions at once: fatigue, very low blood counts, nerve tingling, nausea, and diarrhoea are all common. Modified FOLFIRINOX uses reduced doses of the same drugs and is generally better tolerated.

What does FOLFIRINOX stand for?

FOLFIRINOX is an acronym built from the names of its four drugs: folinic acid, fluorouracil (5-FU), irinotecan, and oxaliplatin.

FOL stands for folinic acid, F for fluorouracil, IRIN for irinotecan, and OX for oxaliplatin.

Folinic acid is not itself cytotoxic — it enhances the way fluorouracil works inside cancer cells.

The remaining three drugs each attack cancer cells by a different mechanism. Combining them is what makes this regimen more intensive than most two-drug combinations.

What side effects does FOLFIRINOX cause?

  • Severe fatigueOften the most disruptive part of treatment, particularly in the days after each cycle.
  • Very low white blood cells (neutropenia)Fever during neutropenia is a medical emergency. Call your team or go to the emergency department the same day — do not wait.
  • Nausea and vomitingAnti-nausea medicines are given during and after treatment. Tell your team if they are not adequately controlling it.
  • DiarrhoeaIrinotecan commonly causes diarrhoea. Severe or persistent diarrhoea needs same-day contact with your team — do not manage it alone at home.
  • Tingling or numbness in hands and feetOxaliplatin causes peripheral neuropathy. Cold sensitivity — pain or intense tingling on touching cold surfaces — is a distinctive early sign.
  • Mouth soresFluorouracil can cause painful sores inside the mouth and throat. Tell your team if eating or drinking becomes difficult.
  • Hair thinning or lossIrinotecan typically causes significant hair loss. Hair usually grows back after treatment finishes, though timing and texture can vary.

Who is FOLFIRINOX not suitable for?

FOLFIRINOX is not appropriate for everyone, and several situations make it unsuitable.

  • Reduced physical fitness. This regimen is intended for people who are well enough to tolerate three active cytotoxic drugs simultaneously. Those with significant limitation in daily activity or low physical reserve are generally not candidates.
  • Pre-existing peripheral neuropathy. Oxaliplatin worsens nerve damage. People who already have numbness, tingling, or pain in their hands or feet are at higher risk of severe and lasting neuropathy on this regimen.
  • Significant liver or kidney impairment. The drugs in FOLFIRINOX are processed through these organs. Impaired clearance increases the risk of serious toxicity.
  • Certain heart conditions. Fluorouracil can affect the heart in some individuals. Pre-existing cardiac disease is assessed carefully before starting treatment.
  • Cancer types without an established indication. FOLFIRINOX is not a general-purpose regimen and is not given outside the cancer types where evidence supports its use.

Eligibility in each case is decided by an oncologist based on individual test results and clinical assessment.

What is modified FOLFIRINOX, and why does it exist?

Modified FOLFIRINOX — written as mFOLFIRINOX — uses lower amounts of one or more of the same four drugs.

It was developed because the standard regimen caused severe side effects in a significant number of patients, particularly those with less physical reserve.

If your chart says modified or mFOLFIRINOX, you are still receiving the same four drugs. The modification is your oncologist's judgement about the version your body is most likely to tolerate.

How do you manage the side effects of FOLFIRINOX?

Do I need a port or central line before starting?

Fluorouracil in FOLFIRINOX is delivered as a slow continuous infusion via a portable pump you carry home. A standard peripheral IV in the arm cannot support this safely over that duration. A central line or implanted port — a small device placed under the skin — is placed before treatment begins. If you do not yet have one, your team will arrange the procedure as part of your preparation. Ask when this is scheduled so you can plan around it.

Why does cold feel painful during treatment?

Oxaliplatin causes cold-induced dysaesthesia — immediate pain or intense tingling in the hands or throat when touching anything cold. This can include a chilled glass, a metal surface, or outdoor air. It often reduces between cycles early in treatment but can become more persistent over time. Tell your team if it is lasting longer after each cycle or beginning to affect daily activity — it is one of the things your oncologist monitors to guide ongoing treatment decisions.

What are growth factor injections and why might I need one?

FOLFIRINOX often causes a significant drop in neutrophils — the white cells that fight bacterial infection — after each cycle. Your oncologist may prescribe G-CSF injections, given under the skin, to help your bone marrow recover these cells faster between cycles. These can usually be given at home by you or a family member after a brief demonstration. If no one has mentioned this and you are concerned about infection risk between cycles, ask your team directly whether you should be having them.

What happens if my blood counts are too low to continue?

Before each cycle, your team checks your blood counts. If white cell or platelet counts have not recovered sufficiently, your next cycle will be delayed until they do. This is a built-in safety step, not a sign that treatment is going badly. Persistent low counts across several cycles is one of the pieces of information your oncologist uses to decide whether adjustments to the regimen are appropriate. Between tests, report any fever, unusual bruising, or signs of bleeding the same day.

Does hair lost during FOLFIRINOX grow back?

Irinotecan commonly causes significant hair loss, typically beginning a few weeks into treatment and affecting hair across the body, not only the scalp. Hair usually begins to regrow after treatment finishes, though the timing, texture, and colour may differ from before. It helps to think about head covering options before your first cycle rather than after. Your nurse can offer practical guidance on what to expect and how to plan for it.

Did you know?

The name FOLFIRINOX encodes all four of its drugs: FOL for folinic acid, F for fluorouracil, IRIN for irinotecan, and OX for oxaliplatin.

Each drug was independently established in cancer treatment before being combined into one regimen — which is also why side effects arrive from four different directions at once.

Source: NCCN Clinical Practice Guidelines in Oncology — Pancreatic Adenocarcinoma

Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics

HUB — Chemotherapy Regimens

HUB — Cycles, Schedules and What Happens on Infusion Day

All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →

Common questions

Frequently asked questions

Is FOLFIRINOX only used for pancreatic cancer?

FOLFIRINOX is most closely associated with pancreatic cancer, where NCCN and ESMO guidance includes it as an option for patients with suitable fitness. It is also used for some other gastrointestinal cancers. Whether it is the right regimen for your specific diagnosis depends on your cancer type, stage, and individual test results — your oncologist will explain why this combination was chosen for you.

How many cycles of FOLFIRINOX do people typically have?

The number of cycles depends on your cancer, the aim of treatment, and how your body responds. There is no fixed number that applies to everyone. Some people receive it for a defined period before surgery; others continue for longer in the non-surgical setting. Your oncologist will tell you the intended plan at the outset and revise it based on scans and how you are tolerating treatment.

What should I do if I get a fever during FOLFIRINOX?

A fever during FOLFIRINOX is a medical emergency. It may indicate febrile neutropenia — fever combined with very low white blood cells — which can become life-threatening within hours because the immune system cannot fight infection normally. ASCO and NCCN guidance treats febrile neutropenia as requiring same-day emergency assessment. Do not wait for the next morning or your next appointment. Call your oncology team immediately, or go directly to the nearest emergency department.

How is FOLFIRINOX different from FOLFOX or FOLFIRI?

FOLFOX combines folinic acid, fluorouracil, and oxaliplatin. FOLFIRI replaces oxaliplatin with irinotecan. FOLFIRINOX contains all four drugs: folinic acid, fluorouracil, oxaliplatin, and irinotecan together. The fourth drug is the key difference. Your oncologist chooses between these regimens based on your cancer type, the goal of treatment, and what your body is likely to tolerate.

Can FOLFIRINOX be given before surgery?

Yes — chemotherapy given before surgery is called neoadjuvant treatment, and FOLFIRINOX is used in this way for some pancreatic cancers. The aim is to reduce the tumour before an operation, or to treat disease that has spread to nearby structures. Whether this approach applies to you depends on your stage and the surgical team's assessment. NCCN guidance sets out criteria for when pre-operative chemotherapy is considered, and your team will explain whether you fall into that group.

What should I do if diarrhoea becomes severe during FOLFIRINOX?

Severe or rapidly worsening diarrhoea on FOLFIRINOX needs same-day contact with your team — not home management with over-the-counter medicine alone. Irinotecan can cause rapid-onset diarrhoea that leads quickly to dehydration. ASCO guidance identifies uncontrolled diarrhoea on chemotherapy as needing prompt medical review. Contact your team the same day if diarrhoea is clearly worse than usual and not settling, or if it comes alongside fever, blood in stool, severe cramping, or difficulty keeping fluids down.

Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12